The global market for Celiac Disease Drugs was valued at US$ 791 million in the year 2024 and is projected to reach a revised size of US$ 2061 million by 2031, growing at a CAGR of 14.9% during the forecast period.

Celiac Disease Drugs Market

Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Celiac Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Disease Drugs.

The Celiac Disease Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Celiac Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Celiac Disease Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Celiac Disease Drugs Market Report

Report Metric	Details
Report Name	Celiac Disease Drugs Market
Accounted market size in year	US$ 791 million
Forecasted market size in 2031	US$ 2061 million
CAGR	14.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	First Line of Treatment Second Line of Treatment
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis, Bristol-Myers Squibb, Immunomedics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Celiac Disease Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Celiac Disease Drugs Market growing?

Ans: The Celiac Disease Drugs Market witnessing a CAGR of 14.9% during the forecast period 2025-2031.

What is the Celiac Disease Drugs Market size in 2031?

Ans: The Celiac Disease Drugs Market size in 2031 will be US$ 2061 million.

Who are the main players in the Celiac Disease Drugs Market report?

Ans: The main players in the Celiac Disease Drugs Market are Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis, Bristol-Myers Squibb, Immunomedics

What are the Application segmentation covered in the Celiac Disease Drugs Market report?

Ans: The Applications covered in the Celiac Disease Drugs Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others

What are the Type segmentation covered in the Celiac Disease Drugs Market report?

Ans: The Types covered in the Celiac Disease Drugs Market report are First Line of Treatment, Second Line of Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Celiac Disease Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 First Line of Treatment

1.2.3 Second Line of Treatment

1.3 Market by Application

1.3.1 Global Celiac Disease Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Celiac Disease Drugs Market Perspective (2020-2031)

2.2 Global Celiac Disease Drugs Growth Trends by Region

2.2.1 Global Celiac Disease Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Celiac Disease Drugs Historic Market Size by Region (2020-2025)

2.2.3 Celiac Disease Drugs Forecasted Market Size by Region (2026-2031)

2.3 Celiac Disease Drugs Market Dynamics

2.3.1 Celiac Disease Drugs Industry Trends

2.3.2 Celiac Disease Drugs Market Drivers

2.3.3 Celiac Disease Drugs Market Challenges

2.3.4 Celiac Disease Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Celiac Disease Drugs Players by Revenue

3.1.1 Global Top Celiac Disease Drugs Players by Revenue (2020-2025)

3.1.2 Global Celiac Disease Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Celiac Disease Drugs Revenue

3.4 Global Celiac Disease Drugs Market Concentration Ratio

3.4.1 Global Celiac Disease Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Drugs Revenue in 2024

3.5 Global Key Players of Celiac Disease Drugs Head office and Area Served

3.6 Global Key Players of Celiac Disease Drugs, Product and Application

3.7 Global Key Players of Celiac Disease Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Celiac Disease Drugs Breakdown Data by Type

4.1 Global Celiac Disease Drugs Historic Market Size by Type (2020-2025)

4.2 Global Celiac Disease Drugs Forecasted Market Size by Type (2026-2031)

5 Celiac Disease Drugs Breakdown Data by Application

5.1 Global Celiac Disease Drugs Historic Market Size by Application (2020-2025)

5.2 Global Celiac Disease Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Celiac Disease Drugs Market Size (2020-2031)

6.2 North America Celiac Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Celiac Disease Drugs Market Size by Country (2020-2025)

6.4 North America Celiac Disease Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Celiac Disease Drugs Market Size (2020-2031)

7.2 Europe Celiac Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Celiac Disease Drugs Market Size by Country (2020-2025)

7.4 Europe Celiac Disease Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Celiac Disease Drugs Market Size (2020-2031)

8.2 Asia-Pacific Celiac Disease Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Celiac Disease Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Celiac Disease Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Celiac Disease Drugs Market Size (2020-2031)

9.2 Latin America Celiac Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Celiac Disease Drugs Market Size by Country (2020-2025)

9.4 Latin America Celiac Disease Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Celiac Disease Drugs Market Size (2020-2031)

10.2 Middle East & Africa Celiac Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Celiac Disease Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Celiac Disease Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Celiac Disease Drugs Introduction

11.1.4 Roche Revenue in Celiac Disease Drugs Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Celiac Disease Drugs Introduction

11.2.4 Merck Revenue in Celiac Disease Drugs Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Celiac Disease Drugs Introduction

11.3.4 Johnson & Johnson Revenue in Celiac Disease Drugs Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 BiolineRx

11.4.1 BiolineRx Company Details

11.4.2 BiolineRx Business Overview

11.4.3 BiolineRx Celiac Disease Drugs Introduction

11.4.4 BiolineRx Revenue in Celiac Disease Drugs Business (2020-2025)

11.4.5 BiolineRx Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Celiac Disease Drugs Introduction

11.5.4 Pfizer Revenue in Celiac Disease Drugs Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Innovate Biopharmaceuticals

11.6.1 Innovate Biopharmaceuticals Company Details

11.6.2 Innovate Biopharmaceuticals Business Overview

11.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Introduction

11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2020-2025)

11.6.5 Innovate Biopharmaceuticals Recent Development

11.7 ImmusanT

11.7.1 ImmusanT Company Details

11.7.2 ImmusanT Business Overview

11.7.3 ImmusanT Celiac Disease Drugs Introduction

11.7.4 ImmusanT Revenue in Celiac Disease Drugs Business (2020-2025)

11.7.5 ImmusanT Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Celiac Disease Drugs Introduction

11.8.4 Novartis Revenue in Celiac Disease Drugs Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Celiac Disease Drugs Introduction

11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2020-2025)

11.9.5 Bristol-Myers Squibb Recent Development

11.10 Immunomedics

11.10.1 Immunomedics Company Details

11.10.2 Immunomedics Business Overview

11.10.3 Immunomedics Celiac Disease Drugs Introduction

11.10.4 Immunomedics Revenue in Celiac Disease Drugs Business (2020-2025)

11.10.5 Immunomedics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Innovate Biopharmaceuticals

List of Tables

Table 1. Global Celiac Disease Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of First Line of Treatment

Table 3. Key Players of Second Line of Treatment

Table 4. Global Celiac Disease Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Celiac Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Celiac Disease Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Celiac Disease Drugs Market Share by Region (2020-2025)

Table 8. Global Celiac Disease Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Celiac Disease Drugs Market Share by Region (2026-2031)

Table 10. Celiac Disease Drugs Market Trends

Table 11. Celiac Disease Drugs Market Drivers

Table 12. Celiac Disease Drugs Market Challenges

Table 13. Celiac Disease Drugs Market Restraints

Table 14. Global Celiac Disease Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Celiac Disease Drugs Market Share by Players (2020-2025)

Table 16. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2024)

Table 17. Ranking of Global Top Celiac Disease Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Celiac Disease Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Celiac Disease Drugs, Headquarters and Area Served

Table 20. Global Key Players of Celiac Disease Drugs, Product and Application

Table 21. Global Key Players of Celiac Disease Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Celiac Disease Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Celiac Disease Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Celiac Disease Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Celiac Disease Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Celiac Disease Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Celiac Disease Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Celiac Disease Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Celiac Disease Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Celiac Disease Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Celiac Disease Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Celiac Disease Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Celiac Disease Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Celiac Disease Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Celiac Disease Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Celiac Disease Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Celiac Disease Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Celiac Disease Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Celiac Disease Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Celiac Disease Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Celiac Disease Drugs Product

Table 49. Roche Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Merck Company Details

Table 52. Merck Business Overview

Table 53. Merck Celiac Disease Drugs Product

Table 54. Merck Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 55. Merck Recent Development

Table 56. Johnson & Johnson Company Details

Table 57. Johnson & Johnson Business Overview

Table 58. Johnson & Johnson Celiac Disease Drugs Product

Table 59. Johnson & Johnson Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 60. Johnson & Johnson Recent Development

Table 61. BiolineRx Company Details

Table 62. BiolineRx Business Overview

Table 63. BiolineRx Celiac Disease Drugs Product

Table 64. BiolineRx Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 65. BiolineRx Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Celiac Disease Drugs Product

Table 69. Pfizer Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 70. Pfizer Recent Development

Table 71. Innovate Biopharmaceuticals Company Details

Table 72. Innovate Biopharmaceuticals Business Overview

Table 73. Innovate Biopharmaceuticals Celiac Disease Drugs Product

Table 74. Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 75. Innovate Biopharmaceuticals Recent Development

Table 76. ImmusanT Company Details

Table 77. ImmusanT Business Overview

Table 78. ImmusanT Celiac Disease Drugs Product

Table 79. ImmusanT Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 80. ImmusanT Recent Development

Table 81. Novartis Company Details

Table 82. Novartis Business Overview

Table 83. Novartis Celiac Disease Drugs Product

Table 84. Novartis Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Bristol-Myers Squibb Company Details

Table 87. Bristol-Myers Squibb Business Overview

Table 88. Bristol-Myers Squibb Celiac Disease Drugs Product

Table 89. Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 90. Bristol-Myers Squibb Recent Development

Table 91. Immunomedics Company Details

Table 92. Immunomedics Business Overview

Table 93. Immunomedics Celiac Disease Drugs Product

Table 94. Immunomedics Revenue in Celiac Disease Drugs Business (2020-2025) & (US$ Million)

Table 95. Immunomedics Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Celiac Disease Drugs Picture

Figure 2. Global Celiac Disease Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Celiac Disease Drugs Market Share by Type: 2024 VS 2031

Figure 4. First Line of Treatment Features

Figure 5. Second Line of Treatment Features

Figure 6. Global Celiac Disease Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Celiac Disease Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Online Pharmacy Case Studies

Figure 11. Others Case Studies

Figure 12. Celiac Disease Drugs Report Years Considered

Figure 13. Global Celiac Disease Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Celiac Disease Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Celiac Disease Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Celiac Disease Drugs Market Share by Players in 2024

Figure 17. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2024

Figure 19. North America Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Celiac Disease Drugs Market Share by Country (2020-2031)

Figure 21. United States Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Celiac Disease Drugs Market Share by Country (2020-2031)

Figure 25. Germany Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Celiac Disease Drugs Market Share by Region (2020-2031)

Figure 33. China Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Celiac Disease Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Celiac Disease Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Celiac Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 51. BiolineRx Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 53. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 54. ImmusanT Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 57. Immunomedics Revenue Growth Rate in Celiac Disease Drugs Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions